{"organizations": [], "uuid": "4b5c7afbc2d7a5a840c05b1dd087a5805a83d8e6", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180201.html", "section_title": "Archive News &amp; Video for Thursday, 01 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-fdas-gottlieb-issues-statement-on/brief-fdas-gottlieb-issues-statement-on-efforts-to-mitigate-impact-of-saline-shortages-during-flu-season-idUSFWN1PR17G", "country": "US", "domain_rank": 408, "title": "BRIEF-FDA's Gottlieb Issues Statement On Efforts To Mitigate Impact Of Saline Shortages During Flu Season", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.445, "site_type": "news", "published": "2018-02-02T04:48:00.000+02:00", "replies_count": 0, "uuid": "4b5c7afbc2d7a5a840c05b1dd087a5805a83d8e6"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-fdas-gottlieb-issues-statement-on/brief-fdas-gottlieb-issues-statement-on-efforts-to-mitigate-impact-of-saline-shortages-during-flu-season-idUSFWN1PR17G", "ord_in_thread": 0, "title": "BRIEF-FDA's Gottlieb Issues Statement On Efforts To Mitigate Impact Of Saline Shortages During Flu Season", "locations": [], "entities": {"persons": [{"name": "scott gottlieb", "sentiment": "negative"}, {"name": "gottlieb", "sentiment": "none"}], "locations": [], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "u.s. food and drug administration", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "brief-fda", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 1 (Reuters) - U.S. Food and Drug Administration Commissioner Scott Gottlieb:\n* FDA COMMISSIONER SCOTT GOTTLIEB ISSUES STATEMENT ON ONGOING EFFORTS TO MITIGATE IMPACT OF SALINE SHORTAGES DURING FLU SEASON\n* FDA‘S GOTTLIEB SAYS “THIS YEAR‘S FLU SEASON HAS BEEN PARTICULARLY CHALLENGING, WITH A NOTABLE NUMBER OF CASES LEADING TO HOSPITALIZATION”\n* FDA‘S GOTTLIEB SAYS “MANAGING THE THOUSANDS OF FLU-RELATED HOSPITALIZATIONS HAS INCREASED THE DEMAND FOR CERTAIN SALINE PRODUCTS”\n* FDA‘S GOTTLIEB - THIS YEAR‘S WORSE-THAN-NORMAL FLU SEASON & WORKAROUNDS DEPLOYED BY HEALTH CARE PROVIDERS HAVE INCREASED DEMAND FOR SALINE, OTHER PRODUCTS Source text for Eikon:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-02T04:48:00.000+02:00", "crawled": "2018-02-02T12:47:21.000+02:00", "highlightTitle": ""}